exemestane
Showing 1 - 25 of 158
Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)
Completed
- Metastatic or Locally-advanced Unresectable Breast Cancer
- BYL719
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 1, 2022
Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)
Completed
- Breast Cancer
- Estrogen Receptor Positive Breast Cancer
- entinostat
- exemestane
-
Denver, Colorado
- +2 more
Dec 14, 2021
Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)
Completed
- Advanced Breast Cancer
- Everolimus
- +2 more
-
Guangzhou, Guangdong, China
- +14 more
Jun 17, 2022
Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in Aurora (Exemestane, Exemestane and tamoxifen)
Completed
- Breast Cancer
- +2 more
- Exemestane
- Exemestane and tamoxifen
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 22, 2022
Blood Vessel Function in Postmenopausal Women With Breast Cancer
Active, not recruiting
- Breast Cancer
- anastrozole
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 17, 2023
Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)
Completed
- Breast Neoplasms
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Yuma, Arizona
- +93 more
Nov 4, 2022
Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United
Active, not recruiting
- Stage 0 Breast Cancer AJCC v6 and v7
- +6 more
- Exemestane
- +6 more
-
Tampa, Florida
- +4 more
Dec 15, 2021
Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- PF-07220060
- +3 more
- (no location specified)
Oct 24, 2023
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +4 more
- (no location specified)
Mar 7, 2023
Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)
Active, not recruiting
- Advanced Breast Cancer
- Entinostat
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy Medical Sciences
Jul 7, 2021
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)
Active, not recruiting
- Breast Neoplasms
- Perjeta Injectable Product
- +13 more
-
Mönchengladbach, GermanyEvangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022
Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)
Not yet recruiting
- Breast Cancer, Early Breast Cancer
- Camizestrant
- +5 more
- (no location specified)
Jul 11, 2023
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,
Not yet recruiting
- Locoregional Recurrence
- +2 more
- Ribociclib
- +4 more
- (no location specified)
Jul 18, 2022
Metastatic Breast Cancer Trial in Springfield, Rochester, Lebanon (17B-estradiol, Letrozole, Anastrozole)
Active, not recruiting
- Metastatic Breast Cancer
- 17B-estradiol
- +3 more
-
Springfield, Massachusetts
- +2 more
Nov 1, 2022